moxonidine has been researched along with Metabolic Diseases in 1 studies
moxonidine: structure given in first source
Metabolic Diseases: Generic term for diseases caused by an abnormal metabolic process. It can be congenital due to inherited enzyme abnormality (METABOLISM, INBORN ERRORS) or acquired due to disease of an endocrine organ or failure of a metabolically important organ such as the liver. (Stedman, 26th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
1 trial available for moxonidine and Metabolic Diseases
| Article | Year |
|---|---|
[Cardiovascular and metabolic diseases. Imidazolin-antagonists and the sympathetic nervous system].
Topics: Antihypertensive Agents; Cardiovascular Diseases; Humans; Imidazoles; Metabolic Diseases; Placebos; | 1998 |